You are here

Eli Lilly

Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance

Yahoo Finance

Thu, 05/1/25 - 11:00 am

Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity

MSN/Reuters

Wed, 04/23/25 - 10:27 pm

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

CNBC

Wed, 04/23/25 - 11:01 am

compounded drugs

Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts

Fierce Pharma

Thu, 04/17/25 - 11:06 pm

BMO Capital Markets

Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s

Yahoo/Bloomberg

Thu, 04/17/25 - 11:34 am

clinical trials

BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics

Yahoo Finance

Thu, 04/17/25 - 11:28 am

BigHat Biosciences

artificial intelligence

machine learning

Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data

Clinical Trials Arena

Tue, 04/15/25 - 11:11 am

Verve Therapeutics

Five Biggest Drug Face-Offs in Pharma History

BioSpace

Wed, 04/9/25 - 11:38 am

Bristol Myers Squibb

HHS leaves door open to future Medicare coverage of obesity drugs

BioSpace

Tue, 04/8/25 - 11:54 am

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

CNBC

Sun, 04/6/25 - 11:40 pm

The top 10 pharma R&D budgets for 2024

Fierce Biotech

Fri, 04/4/25 - 11:30 am

Bristol Myers Squibb

Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal

Fierce Biotech

Thu, 04/3/25 - 10:14 pm

Sangamo Therapeutics

5 Big Pharmas Push Boundaries in Radiopharmaceuticals

BioSpace

Wed, 04/2/25 - 11:38 am

radiopharmaceuticals

Bristol Myers Squibb

Hims & Hers to sell Lilly’s weight-loss drug on its telehealth platform

Investing.com

Tue, 04/1/25 - 11:28 pm

Hims & Hers Health

Eli Lilly Sues Pharmacies Over Unauthorized Tirzepatide Compounding

NASDAQ

Tue, 04/1/25 - 11:23 pm

Eli Lilly’s lepodisiran cuts lipoprotein(a) by 93.9% in Phase II trial

Clinical Trials Arena

Mon, 03/31/25 - 10:55 am

clinical trials

European committee says Lilly Alzheimer's drug shouldn't get marketing approval

Yahoo/AP

Fri, 03/28/25 - 11:13 am

Alzheimer's disease

Lilly adds Alzheimer’s disease care to DTC telehealth platform

Fierce Pharma

Thu, 03/27/25 - 10:40 pm

Alzheimer's disease

Lilly, Novo expand DTC reach of obesity meds after compound win

Pharma Voice

Mon, 03/24/25 - 10:58 am

Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial

MSN/Reuters

Thu, 03/20/25 - 10:18 am

Pages